认领应用
StemCentRx is combining scientific talent from the world's leading enterprises and academic labs, a stem cell centric philosophy, and cutting edge technologies to develop novel cancer therapies and diagnostics.StemCentRx was founded in 2008 with the intent of developing life-changing therapies for cancer patients. We have developed proprietary discovery platforms that yield unprecedented insight into the biology of solid tumors and are being exploited to develop potent new cancer drugs. The company is backed by premier venture investors AV (Artis Ventures) and Founders Fund.
成为钛媒体专业用户,即可查看联系方式
您是否确认要删除该条评论吗?
账号合并
经检测,你是“钛媒体”和“商业价值”的注册用户。现在,我们对两个产品因进行整合,需要您选择一个账号用来登录。无论您选择哪个账号,两个账号的原有信息都会合并在一起。对于给您造成的不便,我们深感歉意。
评论(0)